State Street’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78B Buy
3,678,093
+344,487
+10% +$91.4M 0.05% 287
2026
Q1
$365M Buy
3,333,606
+233,797
+8% +$33.3M 0.01% 663
2025
Q4
$516M Buy
3,099,809
+760,358
+33% +$127M 0.02% 555
2025
Q3
$458M Buy
2,339,451
+195,992
+9% +$32.2M 0.02% 584
2025
Q2
$194M Buy
2,143,459
+604,363
+39% +$47.7M 0.01% 943
2025
Q1
$91.8M Sell
1,539,096
-38,910
-2% -$3.6M ﹤0.01% 1313
2024
Q4
$209M Buy
1,578,006
+879,539
+126% +$82.5M 0.01% 913
2024
Q3
$36.6M Buy
698,467
+442,698
+173% +$20.8M ﹤0.01% 1861
2024
Q2
$15.5M Buy
+255,769
New +$17.7M ﹤0.01% 2298

Other funds holding ALAB

State Street's ALAB Position: Q2 2026 in Review

State Street increased its Astera Labs (ALAB) stake by 10% in Q2 2026, buying an estimated $91.4M and bringing the position to 3,678,093 shares worth $1.78B. The position accounts for 0.05% of the portfolio, ranked #287.

State Street first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • State Street held 3,678,093 shares of Astera Labs worth $1.78B as of Q2 2026.
  • State Street bought 344,487 Astera Labs shares in Q2 2026, an estimated $91.4M.
  • Astera Labs made up 0.05% of State Street's portfolio in Q2 2026, its #287 holding.
  • State Street first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.